Lepicortinolo

Prednisolone, the active ingredient in Lepicortinolo, is a glucocorticoid presented as an injectable formulation for intramuscular and intravenous use. It treats inflammatory and autoimmune disorders, allergic reactions, asthma exacerbations, and rheumatoid arthritis in adults.

GNH USA supplies Lepicortinolo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Prednisolone acts on inflammatory and immune pathways to control a range of conditions.

Inflammatory and autoimmune disorders: reduces inflammation and modulates immune response. Allergic reactions: alleviates severe allergic symptoms. Asthma exacerbations: improves airway inflammation and breathing. Rheumatoid arthritis: decreases joint inflammation and pain.

Prednisolone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Increased blood glucose levels. - Fluid retention and peripheral edema. - Mood changes, including irritability or euphoria. - Insomnia and difficulty sleeping. - Increased appetite and weight gain. - Mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe infections due to immunosuppression. - Adrenal insufficiency on abrupt withdrawal. - Osteoporosis and increased fracture risk. - Gastrointestinal bleeding or ulceration. - Psychosis or severe mood disorders. - Anaphylaxis or severe allergic reaction.

When using Prednisolone, careful monitoring and risk mitigation are essential.

Assess infection risk: screen for active infections before initiating therapy. Monitor blood glucose: adjust diabetic treatment as needed. Evaluate bone health: consider calcium/vitamin D supplementation. Use lowest effective dose: limit duration to reduce adverse effects. Avoid abrupt discontinuation: taper gradually under medical supervision. Store at ambient temperature: keep in original container, protect from moisture.

Prednisolone can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase steroid levels. - Live vaccines: risk of uncontrolled infection. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened gastrointestinal bleeding risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce efficacy. - Antidiabetic agents (insulin, oral hypoglycemics): may require dose adjustment.